Managing Director with Objective Capital Partners
Jack is a Managing Director with Objective Capital Partners as well as being a Life Science investor with Tech Coast Angels and a Partner with Deallus. He brings 48 years of global life science industry experience, 28 years at Eli Lilly and Company and 20 years San Diego biotech, medical device and digital health ecosystem.
Jack has experience ranging from early-stage funding, company growth and development, and major pharmaceutical commercial experience. He is on the Board of BIOCOM and holds a Degree in Pharmaceutical Sciences from Columbia University and an MBA from New York University
Jack will discuss various sources of funding available for life science companies in the U.S. as they move through their stages of development and the expectations of investors.
Theme: Expanding to the U.S.